DOI: 10.1055/s-00000045

Der Nuklearmediziner

References

Hofman MS, Lawrentschuk N, Francis RJ. et al.
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.

Lancet 2020;
395: 1208-1216
DOI: 10.1016/s0140-6736(20)30314-7.

Download Bibliographical Data

Access:
Access: